---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027830"
form_type: "8-K"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:06:38.851415+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Wellgistics Health receives Nasdaq bid-price deficiency notice; 180-day cure period through June 8, 2026

## Summary
- Stock closed below $1.00 for 30 consecutive business days (Oct 27–Dec 9, 2025); violates Nasdaq Listing Rule 5550(a)(2).
- Nasdaq grants 180 calendar days (to June 8, 2026) to regain compliance; eligible for additional 180-day period if other listing standards met.
- Company evaluating options, including a potential reverse stock split; no immediate effect on listing under symbol WGRX.
- Failure to cure could result in delisting; appeal to Nasdaq hearings panel would be available.

## SEC filing metadata
- accession: 0001493152-25-027830
- form_type: 8-K
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000149315225027830/0001493152-25-027830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000149315225027830/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027830
- JSON: https://secwatch.observer/filing/0001493152-25-027830.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027830.txt

## Source-grounded claims
- claim_id: 757fcc644d7df79692f305d3e6ae4e543d2f5c56
  claim: Wellgistics Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: December 9, 2025, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until June 8, 2026 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by June 8, 2026, the Company may be eligible for an additional 180-day period to reg
  evidence_url: https://www.sec.gov/Archives/edgar/data/2030763/000149315225027830/0001493152-25-027830-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.